Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic cystopathy.

S A Kaplan1, J G Blaivas

  • 1Department of Urology, Columbia University, College of Physicians and Surgeons, New York, New York.

The Journal of Diabetic Complications
|July 1, 1988
PubMed
Summary

Diabetic cystopathy, a bladder dysfunction in diabetes, presents subtly with impaired sensation and urinary flow. Treatment depends on symptoms, with timed voiding for asymptomatic cases and clean intermittent catheterization for symptomatic patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Cell communication and signaling : CCS·2021
Same author

Letter to the Editor.

The Canadian journal of urology·2018
Same author

Seventh Report on the Standardisation of Terminology of Lower Urinary Tract Function: Lower Urinary Tract Rehabilitation Techniques.

Scandinavian journal of urology and nephrology·2016
Same author

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER.

International journal of clinical practice·2014
Same author

Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors.

Drugs & aging·2014
Same author

PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH.

Current bladder dysfunction reports·2013

Area of Science:

  • Urology
  • Endocrinology
  • Nephrology

Background:

  • Diabetic cystopathy is a common complication of diabetes mellitus, characterized by voiding dysfunction.
  • It typically presents with insidious onset and minimal initial symptoms.
  • Urodynamic findings often include impaired bladder sensation, increased post-void residual volume, and decreased detrusor contractility.

Purpose of the Study:

  • To review the clinical presentation, urodynamic findings, and management strategies for diabetic cystopathy.
  • To emphasize the importance of tailoring treatment to individual patient symptoms and coexisting conditions.

Main Methods:

  • Review of existing literature on diabetic cystopathy.
  • Analysis of common urodynamic findings and treatment outcomes.

Main Results:

  • Common urodynamic findings include impaired bladder sensation, elevated post-void residual volumes, and reduced detrusor contractility, potentially leading to areflexia and diminished urinary flow.
  • Coexisting urologic conditions, such as bladder outlet obstruction, frequently complicate management.
  • Timed voiding is recommended for asymptomatic patients, while clean intermittent catheterization is essential for symptomatic individuals.

Conclusions:

  • Diabetic cystopathy management requires a personalized approach based on symptom complex and clinical status.
  • Clean intermittent catheterization is the cornerstone of therapy for symptomatic patients.
  • Pharmacologic and surgical interventions have shown limited consistent efficacy.

Related Experiment Videos